Your browser doesn't support javascript.
loading
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals.
Kvitne, Kine Eide; Hovd, Markus; Johnson, Line Kristin; Wegler, Christine; Karlsson, Cecilia; Artursson, Per; Andersson, Shalini; Sandbu, Rune; Hjelmesæth, Jøran; Skovlund, Eva; Jansson-Löfmark, Rasmus; Christensen, Hege; Åsberg, Anders; Robertsen, Ida.
Afiliación
  • Kvitne KE; Department of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway. k.e.kvitne@farmasi.uio.no.
  • Hovd M; Department of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway.
  • Johnson LK; Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
  • Wegler C; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Karlsson C; DMPK, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Artursson P; Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Andersson S; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Sandbu R; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Hjelmesæth J; Oligonucleotide Discovery, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Skovlund E; Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
  • Jansson-Löfmark R; Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
  • Christensen H; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Åsberg A; Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway.
  • Robertsen I; DMPK, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Clin Pharmacokinet ; 63(1): 109-120, 2024 01.
Article en En | MEDLINE | ID: mdl-37993699
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Mórbida / Derivación Gástrica Límite: Humans Idioma: En Revista: Clin Pharmacokinet Año: 2024 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Mórbida / Derivación Gástrica Límite: Humans Idioma: En Revista: Clin Pharmacokinet Año: 2024 Tipo del documento: Article País de afiliación: Noruega